Psyence Biomedical to not proceed with Clairvoyant acquisition [Seeking Alpha]
Psyence Biomedical Ltd. - Ordinary Shares (PBM)
Company Research
Source: Seeking Alpha
PBM after hours to $0.103. Earlier in September, Psyence Biomedical said it has entered into a term sheet with privately held Clairvoyant Therapeutics to acquire 100% of its shareholding. Source: Press Release More on Psyence Biomedical Ltd. Psyence Biomedical receives delisting determination from Nasdaq Psyence Biomedical to acquire drug developer Clairvoyant Financial information for Psyence Biomedical Ltd. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
PBM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PBM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PBM alerts
High impacting Psyence Biomedical Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PBM
News
- Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from NasdaqGlobeNewswire
- Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabsGlobeNewswire
- Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabsGlobeNewswire
- Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Financial Post (Toronto, OntariFinancial Post
PBM
Sec Filings
- 11/13/24 - Form SC
- 11/12/24 - Form 6-K
- 11/12/24 - Form SC
- PBM's page on the SEC website